Dokter Biopsi paru terbaik di luar negeri — Halaman 3

Assoc. Prof. Priv.-Doz. Dr. Alexander W. Hauswirth is a specialist in internal medicine and haemato‑oncology at JUVENIS. Since 2010, he has served as the lead senior physician for Haematology/Haemostaseology and Oncology at the Clinic for Internal Medicine I, Medical University of Vienna/AKH Vienna, Austria’s largest hospital.

He earned his medical degree from the University of Vienna in 1999. He received the venia docendi in 2010 and was appointed Associate Professor in 2012. He completed an additional haemato‑oncology qualification in 2014. As a Schrödinger Fellow in Salamanca in 2009–2010, he researched CLL stem and precursor cells. He has published regularly since 2000.

Accreditations include Austrian Medical Chamber diplomas in emergency medicine (since 2009) and sports medicine (2018). Awards include the Schrödinger Fellowship (2009), the ÖGHO award (2009), and the European Society of Chemotherapy poster award (2003). Clinical focus: anaemias, leukaemias, lymph node disorders, clotting and anticoagulation, and pre‑operative clearance. Languages: German and English.

Dr. Amr Mahmoud Al Demery adalah konsultan bedah onkologi toraks di Rumah Sakit Shefaa Al Orman. Beliau memiliki spesialisasi dalam diagnosis dan perawatan bedah kanker toraks. Dr. Al Demery adalah anggota Royal College of Surgeons of England. Beliau memegang gelar Doktor dalam Bedah Onkologi dari National Cancer Institute.

• Salah satu pendiri dan anggota Egyptian Society of Respiratory Neoplasms.
• Melakukan reseksi paru yang kompleks, termasuk lobektomi dan pneumonektomi.
• Pakar dalam bedah kanker esofagus dan rekonstruksi dinding dada.
• Bekerja di pusat yang terakreditasi ESMO yang menangani 6.000 pasien setiap tahun.

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Dr. Kurt Rasche adalah Kepala Pulmonologi di Rumah Sakit Universitas Helios Wuppertal. Beliau memimpin Pusat Kanker Paru-paru bersertifikat dan departemen kedokteran tidur. Dengan pengalaman klinis selama puluhan tahun, beliau berfokus pada penyakit paru kronis dan gangguan pernapasan. Dr. Rasche merawat pasien di rumah sakit yang menangani 150.000 orang setiap tahunnya.

• Spesialis penyakit dalam, pulmonologi, alergi, dan perawatan intensif.
• Menangani kondisi kompleks termasuk PPOK, asma, pneumonia, dan kanker paru-paru.
• Melakukan dilatasi balon bronkoskopi dan operasi kanker paru-paru.
• Memimpin pusat yang disertifikasi oleh Masyarakat Kanker Jerman.

Dr. Yaacov Lawrence adalah Kepala Onkologi Radiasi di Sheba Medical Center. Beliau memiliki spesialisasi dalam terapi radiasi presisi dan neuro-onkologi. Dr. Lawrence adalah pelopor bedah radio pleksus celiac untuk manajemen nyeri kanker pankreas. Beliau memegang gelar FASTRO, salah satu penghargaan tertinggi di bidang spesialisasi beliau.

• Memimpin Program Kanker Gastrointestinal di Sheba Medical Center.
• Melakukan bedah radio stereotaktik untuk tumor otak dan kanker sistem saraf.
• Penulis lebih dari 280 publikasi ilmiah tentang protokol radiasi yang dipersonalisasi.
• Menyelesaikan pelatihan fellowship onkologi radiasi di Thomas Jefferson University.

Dr. Jair Bar adalah ahli onkologi toraks dan Wakil Direktur Pusat Kanker di Sheba Medical Center. Beliau berspesialisasi dalam mengobati kanker paru-paru sel tidak kecil stadium lanjut menggunakan imunoterapi yang dipersonalisasi dan perawatan bertarget. Dr. Bar memegang gelar PhD dalam Biologi Molekuler dan memimpin laboratorium penelitian yang berfokus pada resistensi imunoterapi.

• Ketua Kelompok Kanker Paru-Paru Israel.
• Bersertifikat dalam Onkologi Medis dan Radioterapi Onkologi.
• Merawat pasien di Sheba Medical Center, salah satu dari 10 rumah sakit terbaik di dunia.
• Menggunakan profil molekuler dan genetik untuk membuat rencana perawatan kanker yang tepat.

Dr. Shute Ailia DAE is a medical oncologist at Optimed International Çorlu Hospital. Dr. Ailia graduated from Dokuz Eylül University Faculty of Medicine in 2013 and completed an internal medicine residency at Bezmialem Vakıf University Hospital in 2018. A hematology–oncology fellowship at Başkent University Hospital followed in 2023.

From 2018 to 2020, Dr. Ailia served as an internal medicine specialist at Bezmialem Vakıf University Hospital. From 2023 to 2024, Dr. Ailia was an instructor in medical oncology at Başkent University Adana Dr. Turgut Noyan Practice and Research Center.

Clinical focus includes breast, lung, and prostate cancers. It also covers gastrointestinal cancers (colon, stomach, esophagus, pancreas, liver), lymphomas, melanoma, and gynecologic and genitourinary cancers. Languages: English, Turkish, Swahili.

Dr. Serkan Deveci adalah ahli urologi dan onko-bedah di Rumah Sakit Medical Park Göztepe, Istanbul. Beliau berspesialisasi dalam pengobatan kanker prostat, ginjal, dan testis. Dr. Deveci adalah seorang profesor dan anggota American Urological Association. Beliau telah menulis lebih dari 20 publikasi internasional mengenai kedokteran seksual dan uro-onkologi.

• Keahliannya mencakup nefrektomi dan prosedur biopsi khusus untuk berbagai kondisi.
• Editor bagian untuk UpToDate, sumber daya pendukung keputusan klinis yang digunakan di seluruh dunia.
• Anggota tim peninjau abstrak American Urological Association.
• Berpraktik di Medical Park Göztepe yang terakreditasi JCI, yang memiliki sertifikasi Pusat Bedah Robotik.

Dokter adalah seorang onkosurgeon dengan pengalaman 25 tahun, yang mengkhususkan diri dalam pengobatan kanker rektum dan kolon, bedah bariatrik, dan pengobatan kanker esofagus.<\/p>

Dengan lebih dari 15.000 prosedur bedah yang dilakukan, dokter melakukan lebih dari 1.000 operasi invasif minimal setiap tahun, menggunakan teknik laparoskopi dan robotik.<\/p>

Sebagai anggota masyarakat medis internasional, dokter adalah presiden Asosiasi Ahli Bedah-Endoskopis di Eropa dan memberikan kuliah tentang teknik bedah lanjutan dan laparoskopi.<\/p>

Dikenal sebagai pelopor dalam bedah gastrointestinal, dokter adalah yang pertama melakukan prosedur terobosan seperti pengangkatan kantong empedu melalui mulut dan eksisi mesorektal total transanal pertama (TaTME).<\/p>

Dokter adalah seorang gastroenterolog terkemuka di Korea Selatan dan Asia, yang mengkhususkan diri dalam penanganan kanker pankreas, saluran empedu, dan kandung empedu, serta pankreatitis dan batu empedu.<\/p>

Saat ini berpraktik di Samsung Medical Center, dokter memiliki latar belakang pendidikan dari Fakultas Kedokteran Universitas Nasional Seoul dan Universitas California.<\/p>

Dokter adalah anggota aktif dari beberapa organisasi profesional, termasuk Masyarakat Endoskopi Gastrointestinal Korea, Masyarakat Gastroenterologi Korea, dan Asosiasi Pankreatobiliari Korea.<\/p>

Dr. Lee memimpin onkologi gastrointestinal di Samsung Medical Center. Beliau melakukan prosedur biopsi paru untuk penentuan stadium kanker yang kompleks.

• Terlatih di Stanford University School of Medicine di Amerika Serikat
• Melakukan biopsi dan operasi untuk kondisi pankreas, hati, dan paru-paru
• Menyelesaikan pelatihan klinis di Kyoto Second Red Cross Hospital di Jepang
• Profesor Gastroenterologi di fakultas kedokteran utama di Korea Selatan
• Anggota Korean Society of Gastrointestinal Endoscopy

Dokter adalah seorang onkoginekologis berprestasi dengan pengalaman luas dalam merawat kanker ginekologi. Mengkhususkan diri dalam teknik bedah lanjutan dan rencana perawatan yang dipersonalisasi, dokter telah berkontribusi secara signifikan dalam meningkatkan hasil pasien. Dengan banyak publikasi di jurnal yang ditinjau sejawat, dokter diakui atas keahliannya dalam prosedur minimal invasif dan telah menjadi pembicara utama di konferensi internasional.<\/p>

Dokter memiliki sertifikasi dewan dalam onkologi ginekologi dan terlibat aktif dalam penelitian klinis, berfokus pada terapi inovatif dan metode deteksi dini. Dokter berafiliasi dengan institusi medis terkemuka dan berkolaborasi dengan tim multidisiplin untuk memberikan perawatan komprehensif.<\/p>

Dr. Ahn Jin Seok adalah ahli onkologi spesialis di Samsung Medical Center. Beliau membawa keahlian klinis tingkat tinggi bagi pasien yang memerlukan biopsi paru-paru.

• Bekerja di Samsung Medical Center – salah satu rumah sakit dengan peringkat teratas di Korea Selatan
• Berspesialisasi dalam onkologi medis untuk diagnosis dan pengobatan tumor
• Ahli onkologi bersertifikat yang berfokus pada identifikasi sel kanker melalui metode diagnostik yang tepat
• Bagian dari tim multidisiplin terkemuka di pusat medis akademik besar

Dokter adalah seorang ginekolog yang sangat terampil dengan fokus khusus dalam onkoginekologi, memberikan perawatan ahli dalam diagnosis dan pengobatan kanker ginekologi. Dengan pengalaman luas dalam pendekatan bedah dan non-bedah, dokter berkomitmen untuk memajukan kesehatan wanita melalui perawatan inovatif dan perawatan penuh kasih.<\/p>

Dokter adalah seorang onkosurgeon berprestasi dengan pengalaman luas dalam urologi. Sebagai Kepala Departemen Urologi Samsung, dokter telah memimpin berbagai prosedur bedah inovatif dan berkontribusi pada kemajuan signifikan di bidang ini. Dokter diakui atas keahliannya dalam teknik minimal invasif dan telah berperan penting dalam mengembangkan protokol baru untuk pengobatan kanker. Dokter sangat dihormati atas komitmennya terhadap perawatan pasien dan telah menerima banyak penghargaan atas kontribusinya dalam penelitian medis dan pendidikan.<\/p>

Dokter adalah seorang ginekolog yang berspesialisasi dalam operasi endoskopi dan laparoskopi. Dengan fokus pada teknik bedah yang minim invasif, dokter terampil dalam melakukan prosedur lanjutan yang meningkatkan pemulihan dan hasil pasien. Dokter memiliki pengalaman luas dalam menangani kasus ginekologi yang kompleks, memanfaatkan teknologi mutakhir untuk memberikan perawatan yang optimal.<\/p>

Dokter adalah seorang mammologis yang sangat berpengalaman, yang mengkhususkan diri dalam bedah payudara. Dengan fokus pada teknik bedah inovatif, dokter memimpin Departemen Bedah Payudara, memastikan perawatan dan hasil pasien yang berkualitas tinggi. Dokter diakui atas kontribusinya dalam pengobatan kanker payudara dan telah menerbitkan banyak artikel penelitian di jurnal medis bergengsi. Dokter juga terlibat dalam uji klinis yang bertujuan untuk meningkatkan terapi kanker payudara dan telah menerima berbagai penghargaan atas keunggulan dalam praktik bedah dan perawatan pasien.<\/p>

Profesor Yoram Kluger adalah spesialis bedah onkologi di Rambam Medical Center. Beliau membawa keahlian akademik senior untuk diagnostik kanker yang kompleks seperti biopsi paru-paru.

• Memimpin Divisi Bedah di salah satu pusat medis terbesar di Israel
• Berfokus pada bedah onkologi – bidang khusus untuk menangani kanker melalui pembedahan
• Memegang gelar Profesor – indikator keahlian medis dan pengajaran tingkat tinggi

Dr. Karen Drumea adalah spesialis radioterapi dan onkologi di Rambam Medical Center. Keahliannya mendukung presisi selama biopsi paru dan perawatan kanker selanjutnya.

• Berspesialisasi dalam onkologi dan radioterapi untuk menargetkan dan mengobati tumor dada
• Bekerja di Rambam Medical Center – rumah sakit pemerintah utama di Israel
• Berfokus pada rencana perawatan yang dipersonalisasi berdasarkan temuan diagnostik

Dokter adalah seorang ahli bedah onkologi terkemuka dengan pengalaman luas dalam urologi. Mengkhususkan diri dalam teknik bedah canggih, dokter telah memberikan kontribusi signifikan di bidang onkologi urologi. Dengan fokus pada prosedur minimal invasif, dokter telah berhasil melakukan banyak operasi kompleks, meningkatkan hasil pasien. Dokter juga aktif terlibat dalam penelitian klinis, berkontribusi pada beberapa publikasi yang ditinjau sejawat dan mempresentasikan temuan di konferensi internasional.<\/p>